A Site Network
Built Different.
Precefi represents some of the most experienced dermatology and ophthalmology sites in the Americas, including sites with Phase I capabilities. Our team brings decades of leadership at companies like Allergan, Regeneron, and AstraZeneca, with direct contributions to the development and approval of products including Botox®, Eylea®, Kybella®, and Opzelura®. Combined with our biomarker services, Appiell virtual platform for real-time patient data, and a one contract, one price model. Precefi delivers a partner, not just a site list.
Explore Our Network of Dermatology and
Ophthalmology Sites
Deep Roots in Dermatology. Built for Today’s Trials.
Precefi’s dermatology site network spans the U.S. and Latin America, with experienced investigators conducting trials across a broad range of indications including atopic dermatitis, psoriasis, acne, hidradenitis suppurativa, alopecia areata, and aesthetics. Our sites are led by board-certified dermatologists with decades of clinical research experience and deep therapeutic expertise. Coordinators are trained on Precefi’s standardized workflows and the Appiell virtual platform, ensuring consistent data quality, high enrollment rates, and real-time study visibility for sponsors. From Phase I–IV clinical trials, our dermatology network delivers the speed, quality, and scale to move your program forward.
Learn More
Expanding Into Ophthalmology. Same Model, New Frontier.
Precefi’s ophthalmology site network brings the same investigator-led, sponsor-focused model that has driven results in dermatology into eye care. Our ophthalmology sites support trials across a broad range of indications including dry eye disease, allergic conjunctivitis, bacterial conjunctivitis, glaucoma, geographic atrophy, and ocular inflammation. Each site is staffed by experienced ophthalmologists and trained coordinators, with full access to the Appiell virtual platform for imaging capture, patient data, and compliance monitoring. From Phase I–IV clinical trials, sponsors get a single point of contact, standardized site operations, and the translational capabilities, including tear biomarker collection, that set Precefi apart from traditional site networks.
Learn More
